MEDFILAMENT LTD

Company Registration Number:
11320840 (England and Wales)

Unaudited micro entity accounts for the year ended 30 April 2023

Period of accounts

Start date: 01 May 2022

End date: 30 April 2023

MEDFILAMENT LTD

Contents of the Financial Statements

for the Period Ended 30 April 2023

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Footnotes to the Balance Sheet - 7

MEDFILAMENT LTD

Company Information

for the Period Ended 30 April 2023




Registered office: Flat 10
248 Finchley Road
London
England
NW3 6DJ
Company Registration Number: 11320840 (England and Wales)

MEDFILAMENT LTD

Profit and Loss Account

for the Period Ended 30 April 2023


2023
£

2022
£
Turnover 14,753 43,452
Income from coronavirus (COVID-19) business support grants 0 0
Other Income 0 0
Cost of Materials ( 175 ) ( 5,692 )
Staff Costs ( 20,222 ) ( 11,082 )
Depreciation and Writeoffs ( 0 ) ( 0 )
Other charges ( 23,516 ) ( 26,131 )
Tax on Profit ( 0 ) ( 104 )
Profit or (Loss) for Period ( 29,160 ) 443

MEDFILAMENT LTD

Balance sheet

As at 30 April 2023


2023
£

2022
£
Called up share capital not paid: 100 100
Fixed Assets: 0 0
Current assets: 9 1,136
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: ( 0 ) ( 0 )
Net current assets (liabilities): 9 1,136
Total assets less current liabilities: 109 1,236
Creditors: amounts falling due after more than one year: ( 0 ) ( 0 )
Provision for liabilities: ( 0 ) ( 0 )
Accruals and deferred income: ( 29,169 ) ( 693 )
Total net assets (liabilities): ( 29,060 ) 543
Capital and reserves: ( 29,060 ) 543

MEDFILAMENT LTD

Balance sheet continued

For the year ending 30 April 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 19 January 2024
And Signed On Behalf Of The Board By:

Name: Daniil Nikitichev
Status: Director

The notes form part of these financial statements

MEDFILAMENT LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2023

  • 1. Employee Information

    Average number of employees: 4

MEDFILAMENT LTD

Footnotes to the Financial Statements

for the Period Ended 30 April 2023

  • 2. Off balance sheet disclosure

    No